AK
Amit Kumar Anit
About Amit Kumar Anit
Data last updated:
Amit Kumar Anit is a Director at Ultravalue Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Ultravalue Pharmaceuticals Private Limited reported revenue of ₹9.75 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ultravalue Pharmaceuticals Private Limited U51900UP2022PTC165514 | Director | 10 Jun 2022 | 2022 | ₹9.75 Cr (FY 2024) | Active |
Board colleagues of Amit Kumar Anit
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lalan Singh | 09633576 | Ultravalue Pharmaceuticals Private Limited | Director |
| Mahesh Prasad Singh | 05118394 | Ultravalue Pharmaceuticals Private Limited | Director |
| Purshottam Kant Bajpai | 07257902 | Ultravalue Pharmaceuticals Private Limited | Director |
| Rakesh Kumar | 05157232 | Ultravalue Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Kumar Anit
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Kumar Anit
Amit Kumar Anit currently holds 1 directorship: Ultravalue Pharmaceuticals Private Limited (Director, since 10 Jun 2022, revenue ₹9.75 Cr (FY 2024)).
Amit Kumar Anit was first appointed on 10 Jun 2022 as Director at Ultravalue Pharmaceuticals Private Limited.
The current boards of Amit Kumar Anit's companies include Lalan Singh (Ultravalue Pharmaceuticals Private Limited), Mahesh Prasad Singh (Ultravalue Pharmaceuticals Private Limited), Purshottam Kant Bajpai (Ultravalue Pharmaceuticals Private Limited), Rakesh Kumar (Ultravalue Pharmaceuticals Private Limited).